Blog
-
Machine learning patents in biotech: getting past § 101
Claims that apply generic machine learning to biological data usually fail § 101. Here is how to tie a model to a concrete lab result, using the USPTO's post-Desjardins guidance and recent Federal Circuit cases.
-
AI drug discovery patents: molecule, method or model?
A molecule your model found is patented like any other compound, while the model itself must clear 35 U.S.C. 101. Here is how composition of matter, method and platform claims compare, and when a trade secret protects the model and data better.
